{"url":"https://lda.senate.gov/api/v1/filings/9637fc11-c7ff-4b74-9da2-8d816bd73eb0/","filing_uuid":"9637fc11-c7ff-4b74-9da2-8d816bd73eb0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2021,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9637fc11-c7ff-4b74-9da2-8d816bd73eb0/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Daniel Faraci","dt_posted":"2021-09-08T10:21:17.203000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"P.O. Box 65459","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20035","registrant":{"id":40044351,"url":"https://lda.senate.gov/api/v1/registrants/40044351/","house_registrant_id":39942,"name":"GRASSROOTS POLITICAL CONSULTING LLC","description":"political consulting company","address_1":"P.O. Box 26042","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22313","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MR. DANIEL FARACI","contact_telephone":"+1 202-642-3977","dt_updated":"2026-03-02T18:43:24.813625-05:00"},"client":{"id":209268,"url":"https://lda.senate.gov/api/v1/clients/209268/","client_id":140,"name":"REVIVE THERAPEUTICS INC.","general_description":"pharmaceutical and therapeutics manufacturer","client_government_entity":false,"client_self_select":null,"state":null,"state_display":null,"country":"CA","country_display":"Canada","ppb_state":null,"ppb_state_display":null,"ppb_country":"CA","ppb_country_display":"Canada","effective_date":"2021-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocating for assistance w/Phase 3 trial for Bucillamine","foreign_entity_issues":"Canadian company listed on CSE","lobbyists":[{"lobbyist":{"id":40330,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"FARACI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}